REMUZZI, GIUSEPPE
 Distribuzione geografica
Continente #
AS - Asia 10.144
EU - Europa 9.395
NA - Nord America 9.377
SA - Sud America 950
AF - Africa 287
OC - Oceania 177
Continente sconosciuto - Info sul continente non disponibili 19
Totale 30.349
Nazione #
US - Stati Uniti d'America 9.023
GB - Regno Unito 3.999
CN - Cina 3.028
SG - Singapore 2.682
IT - Italia 1.400
HK - Hong Kong 914
DE - Germania 901
RU - Federazione Russa 845
NP - Nepal 725
BR - Brasile 717
VN - Vietnam 649
FR - Francia 564
BD - Bangladesh 501
IN - India 398
SE - Svezia 377
FI - Finlandia 336
IE - Irlanda 317
KR - Corea 301
CA - Canada 233
ID - Indonesia 175
JP - Giappone 172
AU - Australia 157
NL - Olanda 136
ES - Italia 97
TR - Turchia 93
AR - Argentina 68
MX - Messico 62
IQ - Iraq 59
PK - Pakistan 59
UA - Ucraina 54
TH - Thailandia 53
PH - Filippine 47
AT - Austria 44
PL - Polonia 43
TW - Taiwan 40
DK - Danimarca 37
IR - Iran 37
ZA - Sudafrica 35
EC - Ecuador 34
CO - Colombia 33
GR - Grecia 33
BE - Belgio 32
LY - Libia 30
MY - Malesia 30
SA - Arabia Saudita 29
CL - Cile 28
EG - Egitto 26
NG - Nigeria 26
NO - Norvegia 26
RO - Romania 26
CH - Svizzera 25
VE - Venezuela 23
EU - Europa 21
CI - Costa d'Avorio 19
DZ - Algeria 19
ET - Etiopia 19
NZ - Nuova Zelanda 19
UZ - Uzbekistan 19
KE - Kenya 18
GH - Ghana 17
MA - Marocco 17
PE - Perù 16
JO - Giordania 15
PY - Paraguay 15
TN - Tunisia 14
BG - Bulgaria 13
PT - Portogallo 13
LB - Libano 11
LK - Sri Lanka 11
AE - Emirati Arabi Uniti 10
IL - Israele 10
HR - Croazia 9
KZ - Kazakistan 9
MW - Malawi 9
A2 - ???statistics.table.value.countryCode.A2??? 8
CR - Costa Rica 8
GG - Guernsey 8
OM - Oman 8
UY - Uruguay 8
AZ - Azerbaigian 7
BO - Bolivia 7
DO - Repubblica Dominicana 7
MN - Mongolia 7
AL - Albania 6
CZ - Repubblica Ceca 6
GT - Guatemala 6
JM - Giamaica 6
PS - Palestinian Territory 6
RS - Serbia 6
SI - Slovenia 6
BH - Bahrain 5
BY - Bielorussia 5
GE - Georgia 5
LU - Lussemburgo 5
MD - Moldavia 5
NI - Nicaragua 5
TT - Trinidad e Tobago 5
UG - Uganda 5
BA - Bosnia-Erzegovina 4
BT - Bhutan 4
Totale 30.260
Città #
Southend 3.670
Singapore 1.377
Hong Kong 847
Seattle 770
Ashburn 687
Chandler 654
San Jose 609
Frankfurt am Main 501
Milan 462
Princeton 443
Wilmington 443
Council Bluffs 400
Beijing 392
Fairfield 347
Dallas 341
Dublin 317
Hangzhou 286
Kathmandu 255
Ho Chi Minh City 212
Lauterbourg 207
Santa Clara 196
Woodbridge 196
Los Angeles 195
Bengaluru 191
Hanoi 190
Nanjing 182
Guangzhou 174
Des Moines 169
Houston 163
Buffalo 158
Ann Arbor 152
The Dalles 147
Boardman 140
Redwood City 137
Columbus 132
New York 131
Shanghai 128
Cambridge 124
Helsinki 109
Jawalakhel 109
Jakarta 105
Munich 85
Hefei 83
Cangzhou 80
Toronto 78
Moscow 74
Hanover 72
Tokyo 71
Shenyang 68
São Paulo 64
Mcallen 55
Rome 55
Seoul 55
Yubileyny 55
Jinan 53
Tianjin 52
Chicago 51
Phoenix 51
Changsha 46
Nuremberg 46
Shenzhen 43
Dearborn 42
Hebei 41
Falls Church 40
Montréal 37
Mountain View 36
Paris 34
London 33
Melbourne 32
San Diego 32
Brisbane 31
Nanchang 29
Madrid 28
Redmond 28
Jiaxing 27
Pokhara 27
Istanbul 26
Haiphong 25
San Francisco 25
Jacksonville 24
Washington 24
Dhaka 23
Florence 23
Mumbai 23
Tripoli 23
Turin 23
Atlanta 22
Baghdad 22
Bangkok 22
Silver Spring 22
Naples 21
Rio de Janeiro 21
Zhengzhou 21
Lahore 20
Huizhou 19
Vienna 19
Warsaw 19
Abidjan 18
Brussels 18
Montreal 18
Totale 18.703
Nome #
Community-based screening for chronic kidney disease, hypertension and diabetes in Dharan 2.066
Summary of the International Conference on Onco-Nephrology: an emerging field in medicine 642
Podocytopathies 585
Chronic kidney disease and cardiovascular risk in six regions of the world (ISN-KDDC) : A cross-sectional study 436
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 354
B7-1 Is Not Induced in Podocytes of Human and Experimental Diabetic Nephropathy 341
At the peak of Covid-19 age and disease severity but not comorbidities are predictors of mortality. Covid-19 burden in Bergamo, Italy 339
Sirtuin 3-dependent mitochondrial dynamic improvements protect against acute kidney injury 309
Endothelial injury and thrombotic microangiopathy in COVID-19 : Treatment with the lectin-pathway inhibitor narsoplimab 299
Rationale and design of the CV-PREVITAL study: an Italian multiple cohort randomised controlled trial investigating innovative digital strategies in primary cardiovascular prevention 288
Stamina therapies: time to call a halt 285
Efficacy of coupled plasma filtration adsorption (CPFA) in patients with septic shock: A multicenter randomised controlled clinical trial 277
Recellularization of well-preserved acellular kidney scaffold using embryonic stem cells 266
Impact of SARS-CoV-2 Omicron and Delta variants in patients requiring intensive care unit (ICU) admission for COVID-19, Northern Italy, December 2021 to January 2022 248
Glomerular Diseases Dependent on Complement Activation, Including Atypical Hemolytic Uremic Syndrome, Membranoproliferative Glomerulonephritis, and C3 Glomerulopathy: Core Curriculum 2015 247
Adding a statin to a combination of ACE inhibitor and ARB normalizes proteinuria in experimental diabetes, which translates into full renoprotection 239
Association of CFHR1 homozygous deletion with acute myelogenous leukemia in the European population 231
Blood pressure, proteinuria, and phosphate as risk factors for progressive kidney disease : a hypothesis 215
Rosuvastatin treatment prevents progressive kidney inflammation and fibrosis in stroke-prone rats 213
Mitochondrial-dependent Autoimmunity in Membranous Nephropathy of IgG4-related Disease 209
Prevalence of hypertension and diabetes and coexistence of chronic kidney disease and cardiovascular risk in the population of the Republic of Moldova 208
The impact of COVID-19 on total mortality in Italy up to November 2020 205
Heparin in pregnant women with previous placenta-mediated pregnancy complications : a prospective, randomized, multicenter, controlled clinical trial 203
A multidrug, antiproteinuric approach to alport syndrome : a ten-year cohort study 202
Renal progenitors derived from human iPSCs engraft and restore function in a mouse model of acute kidney injury 201
ADAMTS13 autoantibodies in patients with thrombotic microangiopathies and other immunomediated diseases 195
State of health and inequalities among Italian regions from 2000 to 2021: a systematic analysis based on the Global Burden of Disease Study 2021 194
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010 192
Updated estimates of excess total mortality in Italy during the circulation of the BA.2 and BA.4-5 Omicron variants: April-July 2022 191
Direct reprogramming of human bone marrow stromal cells into functional renal cells using cell-free extracts 187
Autologous mesenchymal stromal cells and kidney transplantation: a pilot study of safety and clinical feasibility 187
Glomerular hyperfiltration and renal disease progression in type 2 diabetes 184
LOW-LEVELS OF THE ANTICOAGULANT ACTIVITY OF PROTEIN-C IN PATIENTS WITH CHRONIC RENAL-INSUFFICIENCY - AN INHIBITOR OF PROTEIN-C IS PRESENT IN UREMIC PLASMA 178
Blood pressure and metabolic effects of acetyl-L-carnitine in type 2 diabetes: DIABASI randomized controlled trial 175
No Excess Total Mortality in Italy in the First Semester of 2023 at All Ages and in the Working Age Population 174
Time-Trends in Air Pollution Impact on Health in Italy, 1990-2019: An Analysis From the Global Burden of Disease Study 2019 172
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010 172
Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013 169
MYO1E mutations and childhood familial focal segmental glomerulosclerosis 166
Sirtuin3 dysfunction is the key determinant of skeletal muscle insulin resistance by angiotensin II 162
The Cost of Patients with Chronic Kidney Failure Before Dialysis: Results from the IRIDE Observational Study 160
Mesenchymal stromal cells and kidney transplantation : pretransplant infusion protects from graft dysfunction while fostering immunoregulation 158
The GFR and GFR decline cannot be accurately estimated in type 2 diabetics 158
A phase 1, single-dose study of fresolimumab, an anti-TGF-Β antibody, in treatment-resistant primary focal segmental glomerulosclerosis 157
Transplantation-induced ischemia-reperfusion injury modulates antigen presentation by donor renal CD11c1F4/801 macrophages through IL-1R8 regulation 157
Renal Expression of FGF23 in Progressive Renal Disease of Diabetes and the Effect of Ace Inhibitor 154
Eculizumab in a patient with dense-deposit disease 154
The contribution of chronic kidney disease to the global burden of major noncommunicable diseases 153
Sirtuin 3 in acute kidney injury 153
Effect of finerenone on albuminuria in patients with diabetic nephropathy : a randomized clinical trial 151
Residual plasmatic activity of ADAMTS13 correlates with phenotype severity in congenital thrombotic thrombocytopenic purpura 150
Effects of manidipine and delapril in hypertensive patients with type 2 diabetes mellitus: The delapril and manidipine for nephroprotection in diabetes (DEMAND) randomized clinical trial 150
Management of chronic kidney disease and its risk factors in eastern Nepal 149
International Society of Nephrology's perspective on the emergence of chronic kidney diseases of unknown/undetermined etiology 149
ACE inhibition is renoprotective among obese patients with proteinuria 149
Renal primordia activate kidney regenerative events in a rat model of progressive renal disease 147
Impact of the post-COVID-19 condition on health care after the first disease wave in Lombardy 146
Renal effects of atorvastatin and rosuvastatin in patients with diabetes who have progressive renal disease (PLANET I) : a randomised clinical trial 145
Transfer of growth factor receptor mRNA via exosomes unravels the regenerative effect of mesenchymal stem cells 143
Overview of complement activation and regulation 142
Perioperative minimal induction therapy: a further step toward more effective immunosuppression in transplantation 142
Chronic kidney disease in sub-Saharan Africa : a public health priority 140
Preventing renal and cardiovascular risk by renal function assessment: Insights from a cross-sectional study in low-income countries and the USA 138
Measuring and estimating GFR and treatment effect in ADPKD patients : results and implications of a longitudinal cohort study 138
Excess Total Mortality in Italy: An Update to February 2023 with Focus on Working Ages 137
Renal progenitors: An evolutionary conserved strategy for kidney regeneration 135
Both darbepoetin alfa and carbamylated erythropoietin prevent kidney graft dysfunction due to ischemia/reperfusion in rats 135
Erythropoietin, but not the correction of anemia alone, protects from chronic kidney allograft injury 133
Sodium intake, ACE inhibition, and progression to ESRD 132
Paricalcitol for secondary hyperparathyroidism in renal transplantation 129
The Toll-IL-1R member Tir8/SIGIRR negatively regulates adaptive immunity against kidney grafts 128
Translating the basic knowledge of mitochondrial functions to metabolic therapy: role of L-carnitine 128
Abatacept in B7-1-positive proteinuric kidney disease 127
STEC-HUS, atypical HUS and TTP are all diseases of complement activation 127
Rabbit anti-rat thymocyte immunoglobulin preserves renal function during ischemia/reperfusion injury in rat kidney transplantation 127
Mesenchymal stem cells in solid organ transplantation (MiSOT) fourth meeting: Lessons learned from first clinical trials 126
Effect of longacting somatostatin analogue on kidney and cyst growth in autosomal dominant polycystic kidney disease (ALADIN): a randomised, placebo-controlled, multicentre trial 126
Validation of a patient-specific hemodynamic computational model for surgical planning of vascular access in hemodialysis patients 123
Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013 123
ADAMTS13 secretion and residual activity among patients with congenital thrombotic thrombocytopenic purpura with and without renal impairment 123
A novel atypical hemolytic uremic syndrome-associated hybrid CFHR1/CFH gene encoding a fusion protein that antagonizes factor H-dependent complement regulation 122
MicroRNAs in kidney physiology and disease 121
Post-COVID condition: dispensation of drugs and diagnostic tests as proxies of healthcare impact 120
Considerations on clinical drug research in Italy 120
Efficacy and safety of eculizumab in atypical hemolytic uremic syndrome from 2-year extensions of phase 2 studies 119
Rationale, design, and baseline characteristics of ARTS-DN: A randomized study to assess the safety and efficacy of finerenone in patients with type 2 diabetes mellitus and a clinical diagnosis of diabetic nephropathy 118
Combined complement gene mutations in atypical hemolytic uremic syndrome influence clinical phenotype 118
Rituximab in idiopathic membranous nephropathy 118
International Society of Nephrology's 0by25 initiative for acute kidney injury (zero preventable deaths by 2025) : a human rights case for nephrology 118
Organoid Models and Applications in Biomedical Research 118
Cardiovascular risk assessment in low-resource settings : a consensus document of the European Society of Hypertension Working Group on Hypertension and Cardiovascular Risk in Low Resource Settings 117
Two years of SARS-CoV-2 pandemic and COVID-19 in Lombardy, Italy 116
Plasma protein S in chronic renal insufficiency. 116
Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013 116
Immunophenotypic Alterations in Adult Patients with Steroid-Dependent and Frequently Relapsing Nephrotic Syndrome 115
Discordant phenotype in monozygotic twins with renal coloboma syndrome and a PAX2 mutation 115
Lack of the lectin-like domain of thrombomodulin worsens shiga toxin-associated hemolytic uremic syndrome in mice 115
Rare inherited kidney diseases : challenges, opportunities, and perspectives 115
No excess mortality among working-age Italians during the Omicron wave of Covid-19 115
Albuminuria and blood pressure, independent targets for cardioprotective therapy in patients with diabetes and nephropathy: a post hoc analysis of the combined RENAAL and IDNT trials 112
Totale 19.792
Categoria #
all - tutte 96.029
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 96.029


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021117 0 0 0 0 0 0 0 0 0 0 0 117
2021/20221.886 145 77 97 107 133 114 97 116 151 256 105 488
2022/20232.838 358 205 140 392 386 495 101 187 232 77 149 116
2023/20242.013 97 242 94 122 363 79 131 115 73 118 256 323
2024/20254.317 202 458 190 486 240 237 133 613 217 359 466 716
2025/20269.751 866 706 997 614 892 822 1.052 616 1.186 719 849 432
Totale 32.231